Human Medicine:

Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner

21 January 2020

SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB UK & Ireland’s Chief Executive, Arnaud Gueny, has issued the following statement:

“I am pleased to confirm that, following an evaluation process, the NHS has identified SYNLAB UK & Ireland as their preferred strategic partner to transform and deliver pathology services in South East London.” 

“However, the procurement process is ongoing and no contract has been awarded. For this reason, confidentiality requirements remain in place and we are unable to provide any further information or comment at this time.”

“We will be pleased to provide more details as soon as the process is concluded.” 

Arnaud Gueny
CEO
SYNLAB UK & Ireland

Latest Human Medicine News
SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing

13 July 2020 SYNLAB UK & Ireland and Arquer Diagnostics, a UK-based company committed to manufacturing and marketing innovative, non-invasive tests for diagnosing and monitoring…

Read More (about 'SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing')
SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation

7th April 2020 – SYNLAB Laboratory Services, part of Europe’s leading medical diagnostics provider SYNLAB Group, is pleased to announce that the company has successfully…

Read More (about 'SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation')